Recombinant multi-species ATG14/Barkor protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ATG14/Barkor protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Enables GTPase binding activity; phosphatidylinositol 3-kinase inhibitor activity; and protein-membrane adaptor activity. Involved in several processes, including early endosome to late endosome transport; macroautophagy; and phosphatidylinositol 3-kinase/protein kinase B signal transduction. Acts upstream of or within endosome to lysosome transport. Located in autophagosome and phagophore assembly site membrane. Is extrinsic component of omegasome membrane and extrinsic component of phagophore assembly site membrane. Part of phosphatidylinositol 3-kinase complex, class III. Is active in phagophore assembly site. [provided by Alliance of Genome Resources, Feb 2025]
The Alternative Names of target: 4832427M01,ATG14,ATG14L,Atg14,Atg14L,Autophagy-related protein 14-like protein (Atg14L),BARKOR,Barkor,Beclin 1-associated autophagy-related key regulator,D14Ertd114e,D14Ertd436e,KIAA0831,RGD1304610

Target products collectionGo to ATG14/Barkor products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP6602-Ag-1/ GM-Tg-hg-IP6602-Ag-2 Human ATG14/Barkor protein Human
GM-Tg-rg-IP6602-Ag-1/ GM-Tg-rg-IP6602-Ag-2 Rat ATG14/Barkor protein Rat
GM-Tg-mg-IP6602-Ag-1/ GM-Tg-mg-IP6602-Ag-2 Mouse ATG14/Barkor protein Mouse
GM-Tg-cynog-IP6602-Ag-1/ GM-Tg-cynog-IP6602-Ag-2 Cynomolgus/Rhesus macaque ATG14/Barkor protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP6602-Ag-1/ GM-Tg-felg-IP6602-Ag-2 Feline ATG14/Barkor protein Feline
GM-Tg-cang-IP6602-Ag-1/ GM-Tg-cang-IP6602-Ag-2 Canine ATG14/Barkor protein Canine
GM-Tg-bovg-IP6602-Ag-1/ GM-Tg-bovg-IP6602-Ag-2 Bovine ATG14/Barkor protein Bovine
GM-Tg-equg-IP6602-Ag-1/ GM-Tg-equg-IP6602-Ag-2 Equine ATG14/Barkor protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP6602-Ag-1/ GM-Tg-hg-IP6602-Ag-2; GM-Tg-rg-IP6602-Ag-1/ GM-Tg-rg-IP6602-Ag-2;
GM-Tg-mg-IP6602-Ag-1/ GM-Tg-mg-IP6602-Ag-2; GM-Tg-cynog-IP6602-Ag-1/ GM-Tg-cynog-IP6602-Ag-2;
GM-Tg-felg-IP6602-Ag-1/ GM-Tg-felg-IP6602-Ag-2; GM-Tg-cang-IP6602-Ag-1/ GM-Tg-cang-IP6602-Ag-2;
GM-Tg-bovg-IP6602-Ag-1/ GM-Tg-bovg-IP6602-Ag-2; GM-Tg-equg-IP6602-Ag-1/ GM-Tg-equg-IP6602-Ag-2
Products Name ATG14/Barkor protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name ATG14/Barkor
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ATG14/Barkor protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.